Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

DOX vs EPAM

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
DOX
Amdocs Limited

Software - Infrastructure

TechnologyNASDAQ • US
Market Cap$7.06B
5Y Perf.+4.6%
EPAM
EPAM Systems, Inc.

Information Technology Services

TechnologyNYSE • US
Market Cap$5.51B
5Y Perf.-54.7%

DOX vs EPAM — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
DOX logoDOX
EPAM logoEPAM
IndustrySoftware - InfrastructureInformation Technology Services
Market Cap$7.06B$5.51B
Revenue (TTM)$4.58B$5.56B
Net Income (TTM)$572M$387M
Gross Margin37.6%28.5%
Operating Margin17.7%9.9%
Forward P/E8.7x8.2x
Total Debt$826M$144M
Cash & Equiv.$325M$1.30B

DOX vs EPAMLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

DOX
EPAM
StockMay 20May 26Return
Amdocs Limited (DOX)100104.6+4.6%
EPAM Systems, Inc. (EPAM)10045.3-54.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: DOX vs EPAM

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: DOX leads in 5 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. EPAM Systems, Inc. is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
DOX
Amdocs Limited
The Income Pick

DOX carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.

  • Dividend streak 12 yrs, beta 0.58, yield 3.1%
  • Lower volatility, beta 0.58, Low D/E 23.8%, current ratio 1.17x
  • Beta 0.58, yield 3.1%, current ratio 1.17x
Best for: income & stability and sleep-well-at-night
EPAM
EPAM Systems, Inc.
The Growth Play

EPAM is the clearest fit if your priority is growth exposure and long-term compounding.

  • Rev growth 15.4%, EPS growth -14.3%, 3Y rev CAGR 4.2%
  • 48.8% 10Y total return vs DOX's 36.5%
  • PEG 0.70 vs DOX's 1.37
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthEPAM logoEPAM15.4% revenue growth vs DOX's -9.4%
ValueEPAM logoEPAMLower P/E (8.2x vs 8.7x), PEG 0.70 vs 1.37
Quality / MarginsDOX logoDOX12.5% margin vs EPAM's 7.0%
Stability / SafetyDOX logoDOXBeta 0.58 vs EPAM's 1.21
DividendsDOX logoDOX3.1% yield; 12-year raise streak; the other pay no meaningful dividend
Momentum (1Y)DOX logoDOX-24.7% vs EPAM's -34.4%
Efficiency (ROA)DOX logoDOX9.0% ROA vs EPAM's 8.1%, ROIC 15.6% vs 15.5%

DOX vs EPAM — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

DOXAmdocs Limited
FY 2025
Managed services arrangements
66.1%$3.0B
Others
33.9%$1.5B
EPAMEPAM Systems, Inc.
FY 2025
Financial Services Sector
35.5%$1.3B
Other Sectors
25.4%$940M
Software And Hi-Tech Sector
22.2%$822M
Healthcare Sector
16.9%$626M

DOX vs EPAM — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLDOXLAGGINGEPAM

Income & Cash Flow (Last 12 Months)

DOX leads this category, winning 4 of 6 comparable metrics.

EPAM and DOX operate at a comparable scale, with $5.6B and $4.6B in trailing revenue. DOX is the more profitable business, keeping 12.5% of every revenue dollar as net income compared to EPAM's 7.0%. On growth, EPAM holds the edge at +7.6% YoY revenue growth, suggesting stronger near-term business momentum.

MetricDOX logoDOXAmdocs LimitedEPAM logoEPAMEPAM Systems, Inc.
RevenueTrailing 12 months$4.6B$5.6B
EBITDAEarnings before interest/tax$1.0B$684M
Net IncomeAfter-tax profit$572M$387M
Free Cash FlowCash after capex$755M$544M
Gross MarginGross profit ÷ Revenue+37.6%+28.5%
Operating MarginEBIT ÷ Revenue+17.7%+9.9%
Net MarginNet income ÷ Revenue+12.5%+7.0%
FCF MarginFCF ÷ Revenue+16.5%+9.8%
Rev. Growth (YoY)Latest quarter vs prior year+4.1%+7.6%
EPS Growth (YoY)Latest quarter vs prior year+9.0%+18.8%
DOX leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

EPAM leads this category, winning 5 of 7 comparable metrics.

At 12.9x trailing earnings, DOX trades at a 17% valuation discount to EPAM's 15.5x P/E. Adjusting for growth (PEG ratio), DOX offers better value at 2.03x vs EPAM's 4.18x — a lower PEG means you pay less per unit of expected earnings growth.

MetricDOX logoDOXAmdocs LimitedEPAM logoEPAMEPAM Systems, Inc.
Market CapShares × price$7.1B$5.5B
Enterprise ValueMkt cap + debt − cash$7.6B$4.4B
Trailing P/EPrice ÷ TTM EPS12.90x15.53x
Forward P/EPrice ÷ next-FY EPS est.8.74x8.17x
PEG RatioP/E ÷ EPS growth rate2.03x4.18x
EV / EBITDAEnterprise value multiple7.43x6.74x
Price / SalesMarket cap ÷ Revenue1.56x1.01x
Price / BookPrice ÷ Book value/share2.10x1.60x
Price / FCFMarket cap ÷ FCF10.95x8.99x
EPAM leads this category, winning 5 of 7 comparable metrics.

Profitability & Efficiency

DOX leads this category, winning 4 of 7 comparable metrics.

DOX delivers a 16.5% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $11 for EPAM. EPAM carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to DOX's 0.24x.

MetricDOX logoDOXAmdocs LimitedEPAM logoEPAMEPAM Systems, Inc.
ROE (TTM)Return on equity+16.5%+10.7%
ROA (TTM)Return on assets+9.0%+8.1%
ROICReturn on invested capital+15.6%+15.5%
ROCEReturn on capital employed+16.8%+13.3%
Piotroski ScoreFundamental quality 0–966
Debt / EquityFinancial leverage0.24x0.04x
Net DebtTotal debt minus cash$501M-$1.2B
Cash & Equiv.Liquid assets$325M$1.3B
Total DebtShort + long-term debt$826M$144M
Interest CoverageEBIT ÷ Interest expense23.45x
DOX leads this category, winning 4 of 7 comparable metrics.

Total Returns (Dividends Reinvested)

DOX leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in DOX five years ago would be worth $9,650 today (with dividends reinvested), compared to $2,268 for EPAM. Over the past 12 months, DOX leads with a -24.7% total return vs EPAM's -34.4%. The 3-year compound annual growth rate (CAGR) favors DOX at -7.7% vs EPAM's -23.4% — a key indicator of consistent wealth creation.

MetricDOX logoDOXAmdocs LimitedEPAM logoEPAMEPAM Systems, Inc.
YTD ReturnYear-to-date-18.0%-47.9%
1-Year ReturnPast 12 months-24.7%-34.4%
3-Year ReturnCumulative with dividends-21.3%-55.0%
5-Year ReturnCumulative with dividends-3.5%-77.3%
10-Year ReturnCumulative with dividends+36.5%+48.8%
CAGR (3Y)Annualised 3-year return-7.7%-23.4%
DOX leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

DOX leads this category, winning 2 of 2 comparable metrics.

DOX is the less volatile stock with a 0.58 beta — it tends to amplify market swings less than EPAM's 1.21 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DOX currently trades 68.3% from its 52-week high vs EPAM's 46.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricDOX logoDOXAmdocs LimitedEPAM logoEPAMEPAM Systems, Inc.
Beta (5Y)Sensitivity to S&P 5000.58x1.21x
52-Week HighHighest price in past year$95.41$222.53
52-Week LowLowest price in past year$62.75$99.67
% of 52W HighCurrent price vs 52-week peak+68.3%+46.9%
RSI (14)Momentum oscillator 0–10041.922.5
Avg Volume (50D)Average daily shares traded980K1.3M
DOX leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates DOX as "Buy" and EPAM as "Buy". Consensus price targets imply 88.7% upside for EPAM (target: $197) vs 38.2% for DOX (target: $90). DOX is the only dividend payer here at 3.08% yield — a key consideration for income-focused portfolios.

MetricDOX logoDOXAmdocs LimitedEPAM logoEPAMEPAM Systems, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$90.00$197.00
# AnalystsCovering analysts1137
Dividend YieldAnnual dividend ÷ price+3.1%
Dividend StreakConsecutive years of raises12
Dividend / ShareAnnual DPS$2.01
Buyback YieldShare repurchases ÷ mkt cap+7.8%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

DOX leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). EPAM leads in 1 (Valuation Metrics).

Best OverallAmdocs Limited (DOX)Leads 4 of 6 categories
Loading custom metrics...

DOX vs EPAM: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is DOX or EPAM a better buy right now?

For growth investors, EPAM Systems, Inc.

(EPAM) is the stronger pick with 15. 4% revenue growth year-over-year, versus -9. 4% for Amdocs Limited (DOX). Amdocs Limited (DOX) offers the better valuation at 12. 9x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate Amdocs Limited (DOX) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — DOX or EPAM?

On trailing P/E, Amdocs Limited (DOX) is the cheapest at 12.

9x versus EPAM Systems, Inc. at 15. 5x. On forward P/E, EPAM Systems, Inc. is actually cheaper at 8. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: EPAM Systems, Inc. wins at 0. 70x versus Amdocs Limited's 1. 37x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — DOX or EPAM?

Over the past 5 years, Amdocs Limited (DOX) delivered a total return of -3.

5%, compared to -77. 3% for EPAM Systems, Inc. (EPAM). Over 10 years, the gap is even starker: EPAM returned +48. 8% versus DOX's +36. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — DOX or EPAM?

By beta (market sensitivity over 5 years), Amdocs Limited (DOX) is the lower-risk stock at 0.

58β versus EPAM Systems, Inc. 's 1. 21β — meaning EPAM is approximately 111% more volatile than DOX relative to the S&P 500. On balance sheet safety, EPAM Systems, Inc. (EPAM) carries a lower debt/equity ratio of 4% versus 24% for Amdocs Limited — giving it more financial flexibility in a downturn.

05

Which is growing faster — DOX or EPAM?

By revenue growth (latest reported year), EPAM Systems, Inc.

(EPAM) is pulling ahead at 15. 4% versus -9. 4% for Amdocs Limited (DOX). On earnings-per-share growth, the picture is similar: Amdocs Limited grew EPS 18. 8% year-over-year, compared to -14. 3% for EPAM Systems, Inc.. Over a 3-year CAGR, EPAM leads at 4. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — DOX or EPAM?

Amdocs Limited (DOX) is the more profitable company, earning 12.

5% net margin versus 6. 9% for EPAM Systems, Inc. — meaning it keeps 12. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DOX leads at 18. 2% versus 9. 6% for EPAM. At the gross margin level — before operating expenses — DOX leads at 36. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is DOX or EPAM more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, EPAM Systems, Inc. (EPAM) is the more undervalued stock at a PEG of 0. 70x versus Amdocs Limited's 1. 37x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, EPAM Systems, Inc. (EPAM) trades at 8. 2x forward P/E versus 8. 7x for Amdocs Limited — 0. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EPAM: 88. 7% to $197. 00.

08

Which pays a better dividend — DOX or EPAM?

In this comparison, DOX (3.

1% yield) pays a dividend. EPAM does not pay a meaningful dividend and should not be held primarily for income.

09

Is DOX or EPAM better for a retirement portfolio?

For long-horizon retirement investors, Amdocs Limited (DOX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

58), 3. 1% yield). Both have compounded well over 10 years (DOX: +36. 5%, EPAM: +48. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between DOX and EPAM?

Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: DOX is a small-cap deep-value stock; EPAM is a small-cap high-growth stock. DOX pays a dividend while EPAM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

DOX

Income & Dividend Stock

  • Sector: Technology
  • Market Cap > $100B
  • Net Margin > 7%
  • Dividend Yield > 1.2%
Run This Screen
Stocks Like

EPAM

Quality Business

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform DOX and EPAM on the metrics below

Revenue Growth>
%
(DOX: 4.1% · EPAM: 7.6%)
Net Margin>
%
(DOX: 12.5% · EPAM: 7.0%)
P/E Ratio<
x
(DOX: 12.9x · EPAM: 15.5x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.